Feluda, first desi Covid detector, gets regulator nod
(World News Science)

NEW DELHI/MUMBAI: An indigenously developed test that uses the cutting-edge CRISPR gene-editing technology to detect the SARS-CoV-2 virus that causes the Covid-19 infection accurately, cheaply and quickly has been approved for commercial launch by the Drugs Controller General of India. Developed by scientists from the Council of Scientific and Industrial Research`s IGIB (Institute of Genomics and Integrative Biology) in Delhi, along with the Tata Group, the test – named Feluda – will diagnose the virus in two hours. “The Tata CRISPR test is the world`s first diagnostic test to deploy a specially...